Commentary on incidence of primary aldosteronism: current estimations based on objective data.
D000236:Adenoma / Q000453:epidemiology; D000310:Adrenal Gland Neoplasms / Q000453:epidemiology; D000311:Adrenal Glands / Q000032:analysis; D000450:Aldosterone / Q000652:urine; D001794:Blood Pressure / Q000187:drug effects; D003900:Desoxycorticosterone / Q000494:pharmacology; D004573:Electrolytes / Q000097:blood / Q000652:urine; D005951:Glucose Tolerance Test; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis / Q000453:epidemiology*; D006973:Hypertension / Q000209:etiology; D007008:Hypokalemia / Q000139:chemically induced; D012083:Renin / Q000097:blood; D012964:Sodium / Q000494:pharmacology; D013148:Spironolactone / Q000494:pharmacology; D013843:Thiazines / Q000494:pharmacology
D004573:Electrolytes; D013843:Thiazines; D013148:Spironolactone; D003900:Desoxycorticosterone; D000450:Aldosterone; D012964:Sodium; D012083:Renin